Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cassady, Remy"'
Autor:
Jesus D. Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub, William B. Donnellan, Jesus Berdeja, Prafulla Bhagat, Karen Fehn, Cassady Remy, Sakshi Jasra, Mohammed Kazemi, Kith Pradhan, Mimi Kim, Ioannis Mantzaris, R. Alejandro Sica, Nishi Shah, Mendel Goldfinger, Noah Kornblum, Kira Gritsman, Ira Braunschweig, Ulrich Steidl, Britta Will, Aditi Shastri, Amit Verma
Publikováno v:
Clinical Cancer Research. 29:60-66
Purpose: Thrombocytopenia is a serious complication of myelodysplastic syndromes (MDS) associated with an increased bleeding risk and worse prognosis. Eltrombopag (ELT), a thrombopoietin receptor agonist, can increase platelet counts and reverse anti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0404ea6f82157e541783874a978241b5
https://doi.org/10.1158/1078-0432.ccr-22-1457
https://doi.org/10.1158/1078-0432.ccr-22-1457
Autor:
Amit Verma, Aditi Shastri, Britta Will, Ulrich Steidl, Ira Braunschweig, Kira Gritsman, Noah Kornblum, Mendel Goldfinger, Nishi Shah, R. Alejandro Sica, Ioannis Mantzaris, Mimi Kim, Kith Pradhan, Mohammed Kazemi, Sakshi Jasra, Cassady Remy, Karen Fehn, Prafulla Bhagat, Jesus Berdeja, William B. Donnellan, Abdulraheem Yacoub, Suman Kambhampati, Jesus D. Gonzalez-Lugo
Supplemental Figure 1. Overall Survival Responders vs Non-Responders Supplemental Figure 2. Overall Survival Among Groups
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3cf496686dd19fa5b10d5494cc344ad
https://doi.org/10.1158/1078-0432.22489251
https://doi.org/10.1158/1078-0432.22489251
Autor:
Amit Verma, Aditi Shastri, Britta Will, Ulrich Steidl, Ira Braunschweig, Kira Gritsman, Noah Kornblum, Mendel Goldfinger, Nishi Shah, R. Alejandro Sica, Ioannis Mantzaris, Mimi Kim, Kith Pradhan, Mohammed Kazemi, Sakshi Jasra, Cassady Remy, Karen Fehn, Prafulla Bhagat, Jesus Berdeja, William B. Donnellan, Abdulraheem Yacoub, Suman Kambhampati, Jesus D. Gonzalez-Lugo
Purpose:Thrombocytopenia is a serious complication of myelodysplastic syndromes (MDS) associated with an increased bleeding risk and worse prognosis. Eltrombopag (ELT), a thrombopoietin receptor agonist, can increase platelet counts and reverse anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d2220d250a4f0d48965425b1d6c76cc
https://doi.org/10.1158/1078-0432.c.6532914.v1
https://doi.org/10.1158/1078-0432.c.6532914.v1
Autor:
Jesus D, Gonzalez-Lugo, Suman, Kambhampati, Abdulraheem, Yacoub, William B, Donnellan, Jesus, Berdeja, Prafulla, Bhagat, Karen, Fehn, Cassady, Remy, Sakshi, Jasra, Mohammed, Kazemi, Kith, Pradhan, Mimi, Kim, Ioannis, Mantzaris, R Alejandro, Sica, Nishi, Shah, Mendel, Goldfinger, Noah, Kornblum, Kira, Gritsman, Ira, Braunschweig, Ulrich, Steidl, Britta, Will, Aditi, Shastri, Amit, Verma
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research.
Thrombocytopenia is a serious complication of MDS associated with an increased bleeding risk and worse prognosis. Eltrombopag (ELT), a thrombopoietin receptor agonist, can increase platelet counts and reverse anti-megakaryopoietic effects of lenalido
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::103d2e99cdc4bb03816a9caa11ac89bd
https://pubmed.ncbi.nlm.nih.gov/36255372
https://pubmed.ncbi.nlm.nih.gov/36255372
Autor:
Cassady Remy, Mendel Goldfinger, Lizamarie Bachier-Rodriguez, Abdulraheem Yacoub, Ira Braunschweig, Mohammad Kazemi, Noah Kornblum, Amit Verma, William B. Donnellan, R. Alejandro Sica, Britta Will, Karen Fehn, Prafulla Bhagat, Ulrich Steidl, Aditi Shastri, Sakshi Jasra, Jesus D. Gonzalez-Lugo, Kira Gritsman, Suman Kambhampati, Ioannis Mantzaris
Publikováno v:
Blood. 138:65-65
Introduction: Lenalidomide (LEN) is approved for treatment of Myelodysplastic Syndrome (MDS) with chromosome 5q deletion (del 5q) as it has shown to induce disease remission and transfusion independence in close to 65% of this population. For patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cde97ba4a6562badafc5d3b63fa3b3ea
https://doi.org/10.1182/blood-2021-146597
https://doi.org/10.1182/blood-2021-146597
Publikováno v:
The Journal of the American Osteopathic Association. 117(5)
Context Previous studies of the Complete Health Improvement Program (CHIP) have demonstrated short-term improvements in select metabolic and cardiovascular biomarkers in community-based programs. However, less is known about the benefits of an employ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4974a439f8b5ac02eb7f0ff6df7c0094
https://pubmed.ncbi.nlm.nih.gov/28459488
https://pubmed.ncbi.nlm.nih.gov/28459488